Page 2 - Ming Yan News Today

Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell AnalysisFREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 -- Cytek...

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $8.16, but opened at $7.93. Cytek Biosciences shares last traded at $8.09, with a volume of 30,759 shares traded. Analyst Upgrades and Downgrades Several analysts have recently weighed in on […]

Stephens began coverage on shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) in a research report sent to investors on Thursday, MarketBeat.com reports. The brokerage issued an overweight rating and a $9.00 target price on the stock. A number of other brokerages also recently issued reports on CTKB. Piper Sandler decreased their price target on […]

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 8,380,000 shares, an increase of 5.8% from the October 31st total of 7,920,000 shares. Approximately 7.2% of the company’s stock are sold short. […]

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) saw a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 8,380,000 shares, a growth of 5.8% from the October 31st total of 7,920,000 shares. Approximately 7.2% of the shares of the company are sold short. Based […]

Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective trimmed by Morgan Stanley from $8.00 to $7.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also commented on CTKB. Raymond James initiated coverage on Cytek Biosciences […]

The move reflects a similar trend globally where countries are stepping up their scrutiny of investments to protect critical industries. Read more at straitstimes.com.

On September 19, 2023, Ming Yan, the Chief Technology Officer (CTO) of Cytek Biosciences Inc (NASDAQ:CTKB), sold 20,000 shares of the company.

Hhlr Advisors LTD. reduced its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 11.3% in the first quarter, according to its most recent filing with the SEC. The fund owned 7,703,514 shares of the company’s stock after selling 981,016 shares during the period. Cytek Biosciences makes up 1.3% of Hhlr Advisors […]

Protégé Ventures has launched Fund II to support startups led by student founders, while Cambridge Associates MD Ming Yan has relocated to Singapore.